Generating improvement in spinal cord injuries

Generating improvement in spinal cord injuries

A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1. The positive efficacy results from an ongoing research study were announced on Jan. 24 in a conference held by Asterias Biotherapeutics, Inc., the biotechnology company that manufactures AST-OPC1..

Source: Medical Xpress

Read More

  • American Academy of Orthopaedic Surgeons
  • North American Spine Society
  • Fairview
  • Minnesota Valley Surgery Center
  • St. Francis Regional Medical Center
  • Haemochromatosis Australia - Inherited iron overload disorder